Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Guam for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Guam only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Guam (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Samuel Friedman (NPI 1891747069)

Field	Value
Entity Type	Individual
Organization	Samuel Friedman
Address	Guam Medical Plaza
City	Tamuning
State	GU
ZIP	96913
Taxonomy	Hematology & Oncology Physician
NPI Enumerated	May 16, 2006

Payer Source	Total Paid
Medicare	$351.7K
Medicaid	$0

Key Findings

This provider’s billed footprint is concentrated in Medicare: Total Medicare revenue is $351.7K and there is no Medicaid billing on file (none below), making the practice effectively single‑payer in the available claims data. The absence of Medicaid activity suggests limited Medicaid patient volume or non‑participation in that program rather than a balanced payer mix.

Revenue concentration is high: the precomputed top 3 Medicare codes by revenue account for 64.6% of this provider's total Medicare revenue, driven by 99213 (29.2%), J3315 (21.3%), and J0881 (14.1%). Those three codes dominate the revenue profile and indicate where the provider’s billing and clinical effort are focused.

The code mix and volumes indicate an outpatient hematology/oncology practice that delivers frequent office visits and infusion/injectable therapies. High counts for chemotherapy administration (96413: 317 claims, $34.9K revenue, 10.6% of Medicare revenue) plus multiple infusion add‑ons (96415: 341 claims, $8.2K revenue) and injection codes (J3315: 242 claims, $70.4K revenue) are consistent with regular) clinic‑based infusion and hormone/oncologic injection services.

99213 is an extreme statistical outlier for this provider: it generates $96.4K in revenue (29.2% of Medicare revenue) across 1.5K claims and the provider ranks #2337 of 457151 providers nationally (99th percentile; extreme outlier, far above typical national volume for this code). This suggests unusually high Medicare established‑patient office visit volume relative to national peers and a clinic workflow oriented toward many short outpatient encounters.

J3315 (injection, triptorelin) is a major revenue driver with $70.4K (21.3% of Medicare revenue) across 242 claims and the provider ranks #9 of 73 providers nationally (89th percentile; typical, unremarkable volume for this code). The high rank within a small cohort of providers using this specific drug indicates focused use of hormone‑suppression therapy consistent with oncologic or urologic indications in the practice mix.

J0881 (darbepoetin alfa) contributes $46.6K (14.1% of Medicare revenue) with 23.3K claims and the provider ranks #253 of 1114 providers nationally (77th percentile; typical, unremarkable volume for this code). Its presence at meaningful scale points to active management of anemia in the clinic population, likely tied to oncology supportive care.

Multiple infusion and administration codes show above‑typical national participation, signaling substantial infusion throughput: 96415 ranks #189 of 4959 providers nationally (96th percentile; notably above typical national volume for this code) and 96375 ranks #367 of 5191 providers nationally (93th percentile). Together with chemotherapy codes like 96413 (10.6% of Medicare revenue), these percentiles support an operational profile centered on frequent IV drug administration and clinic infusion capacity.

The provider has been enumerated for approximately two decades (NPI enumerated 2006-05-16, ~20 years ago), indicating long tenure in the NPI registry. Combined with the Medicare revenue concentration and the code mix dominated by oncology visits and infusion services, the data portray an established outpatient oncology practice with limited Medicaid exposure and a nationally notable intensity for certain Medicare services.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

36 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	1,460	$70	$96.4K
J3315	Injection, triptorelin pamoate, 3.75 mg	240	$290	$70.4K
J0881	Injection, darbepoetin alfa, 1 microgram (non-esrd use)	23,300	$1	$46.6K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	320	$110	$34.9K
96401	The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient.	220	$60	$12.1K
96417	In this add–on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report administration of a different chemotherapy…	160	$60	$8.9K
96375	Following the administration of a drug or other substance via intravenous, or IV, push, the provider sequentially infuses a different medication or medications, also via IV push. He administers the…	670	$10	$8.7K
96365	The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease.	170	$50	$8.3K
96415	In this add on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report each additional hour of infusion beyond the…	340	$20	$8.2K
51720	This is a common treatment for bladder cancer. It involves instilling an anticarcinogenic agent into the bladder through a catheter. The provider leaves the agent in the bladder for a period of time…	90	$70	$6.6K

Showing 1–10 of 36

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 36 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Guam Distribution

Samuel Friedman — 9 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Guam

Full comparison — all codes billed, vs. state median

36 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J3315	1	10	240	$290	$70.5K
J0881	1	10	23,300	$1	$54.6K
99214	66	90	140	$90	$25.7K
96413	1	10	190	$110	$20.6K
96401	1	10	220	$60	$12K
J1447	1	10	34,500	$1	$10.6K
99213	1	100	100	$60	$10.6K
99204	42	50	30	$110	$6.7K
96417	1	10	120	$60	$6.7K
51720	1	10	90	$70	$6.6K

Showing 1–10 of 36

Related Providers

Other providers that share a Tax Identification Number (TIN) with Samuel Friedman, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Jeffrey Crowley	CA	Dermatology Physician	$2.3M	$0
Alison Chang	CA	Hematology & Oncology Physician	$1.8M	$0
Horng Bruce Lin	CA	Vascular & Interventional Radiology Physician	$1.7M	$0
Harrison Wang	CA	Diagnostic Radiology Physician	$1.3M	$0
Daniel Schiffner	CA	Radiation Oncology Physician	$1.1M	$0
Frank Lai	CA	Urology Physician	$879.4K	$0
George Tischenko	CA	Orthopaedic Surgery Physician	$683.5K	$0
Philip Delio	CA	Neurology Physician	$601K	$0
Roby Lal	IL	Radiation Oncology Physician	$459.5K	$0
Duke Khuu	CA	Dermatology Physician	$415K	$22.7K

Nearby Providers

Other providers in the same ZIP code as Samuel Friedman, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Thomas Lee	GU	Dentist	$0	$10.9M
Guam Memorial Hospital	GU	General Acute Care Hospital	$0	$3.5M
Rsa - Tumon, LLC	GU	End-Stage Renal Disease (ESRD) Treatment Clinic/Center	$0	$2.9M
Robert Yang	GU	Dentist	$0	$2.4M
Antonio Garcia	GU	Pediatrics Physician	$0	$2.2M
Ma Gladys Linsangan	GU	Pediatrics Physician	$0	$2.2M
Ari Katerelos	GU	Radiation Oncology Physician	$2.1M	$0
Guam X-ray	GU	Vascular & Interventional Radiology Physician	$0	$2.1M
Sarah Clegg	GU	General Practice Dentistry	$0	$1.7M
Peter Kh Go	GU	Surgery Physician	$152.8K	$1.5M

Samuel Friedman — Billing Profile & Reimbursement Data

Sign up for Samuel Friedman — Billing Profile & Reimbursement Data policy alerts

Samuel Friedman — Billing Profile & Reimbursement Data

Sign up for Samuel Friedman — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References